Eyelid ptosis vs brow ptosis after toxin — how do you tell them apart and manage?
I get confused between the two. Can someone lay out how to distinguish eyelid droop from brow heaviness after toxin, and what actually helps?
For licensed aesthetic professionals only. Guidance here supports — and never replaces — your clinical judgement. Do not upload identifiable patient data.
I get confused between the two. Can someone lay out how to distinguish eyelid droop from brow heaviness after toxin, and what actually helps?
They're different problems with different causes: • BROW ptosis (heaviness): the frontalis has been over-weakened, so the brow sits lower and the upper lid feels hooded. It's a positioning problem. Prevention is assessment and conservative forehead dosing; it settles as the toxin wears off, and sometimes a tiny dose to the lateral brow depressors can lift slightly. • EYELID ptosis (true lid droop): toxin has diffused to the levator palpebrae superioris, so the upper eyelid itself drops. This usually appears within days to ~2 weeks. Apraclonidine 0.5% eye drops (or an equivalent alpha-agonist) can stimulate Müller's muscle and give ~1–2mm of temporary lift while it recovers. Reassure the patient it's temporary (typically weeks). Prevention for lid ptosis: accurate glabellar placement, correct depth/volume, don't over-dilute into large spreads, and keep away from the mid-pupillary line low on the forehead. Always warn about both at consent.
Worth having the apraclonidine route thought through BEFORE it happens — knowing how your patient would access it (via the prescriber) turns a scary call into a calm one.
Saving this. The 'brow = positioning, lid = levator diffusion' framing finally made it click for me.
Sign in to reply and react.